This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Butcher, S. P. Articles by McCulloch, J. Search for Related Content PubMed PubMed Citation Articles by Butcher, S. P. Articles by McCulloch, J.

Stroke, Vol 21, 1727-1733, Copyright © 1990 by American Heart Association

ARTICLES

Correlation between amino acid release and neuropathologic outcome in rat brain following middle cerebral artery occlusion

SP Butcher, R Bullock, DI Graham and J McCulloch
Department of Pharmacology, University of Edinburgh Medical School, U.K.

Using in vivo brain microdialysis, we studied amino acid release in the striatum and cortex of eight rats following permanent middle cerebral artery occlusion. We then processed all brains for histopathologic assessment of the volume of ischemic damage 4 hours after occlusion. Ischemic damage was varied by occlusion of the middle cerebral artery at a point either proximal (n = 4) or distal (n = 4) to the lenticulostriate vessels. Proximal occlusion elevated the dialysate contents of all amino acids. The largest increases occurred for the potentially neurotoxic amino acids aspartate and glutamate and for taurine (800-2,800% of basal efflux). We observed smaller increases for the "metabolic" amino acids (280-580% of basal efflux). Distal occlusion did not affect amino acid efflux in the striatum, and release in the cortex was significantly lower than that following proximal occlusion. We compared release data with acute histopathologic outcome. Proximal occlusion resulted in a large volume of ischemic damage in the cortex and striatum (25-48% of hemispheric volume). A smaller volume of ischemic damage was noted following distal occlusion (0-21% of hemispheric volume). The volume of ischemic damage and the amount of amino acid release were significantly correlated (p less than 0.05).

This article has been cited by other articles:

				J. Ponce, N. P. de la Ossa, O. Hurtado, M. Millan, J. F. Arenillas, A. Davalos, and T. Gasull Simvastatin Reduces the Association of NMDA Receptors to Lipid Rafts: A Cholesterol-Mediated Effect in Neuroprotection Stroke, April 1, 2008; 39(4): 1269 - 1275. [Abstract] [Full Text] [PDF]

				M. Umegaki, Y. Sanada, Y. Waerzeggers, G. Rosner, T. Yoshimine, W.-D. Heiss, and R. Graf Peri-Infarct Depolarizations Reveal Penumbra-Like Conditions in Striatum J. Neurosci., February 9, 2005; 25(6): 1387 - 1394. [Abstract] [Full Text] [PDF]

				P J Hutchinson, M T O'Connell, P G Al-Rawi, C R Kett-White, A K Gupta, L B Maskell, J D Pickard, and P J Kirkpatrick Increases in GABA concentrations during cerebral ischaemia: a microdialysis study of extracellular amino acids J. Neurol. Neurosurg. Psychiatry, January 1, 2002; 72(1): 99 - 105. [Abstract] [Full Text] [PDF]

				C. Iadecola, K. Niwa, S. Nogawa, X. Zhao, M. Nagayama, E. Araki, S. Morham, and M. E. Ross Reduced susceptibility to ischemic brain injury and N-methyl-D-aspartate-mediated neurotoxicity in cyclooxygenase-2-deficient mice PNAS, January 30, 2001; 98(3): 1294 - 1299. [Abstract] [Full Text] [PDF]

				A. Melani, L. Pantoni, C. Corsi, L. Bianchi, A. Monopoli, R. Bertorelli, G. Pepeu, F. Pedata, and D. K. J. E. von Lubitz Striatal Outflow of Adenosine, Excitatory Amino Acids, {gamma}-Aminobutyric Acid, and Taurine in Awake Freely Moving Rats After Middle Cerebral Artery Occlusion : Correlations With Neurological Deficit and Histopathological Damage • Editorial Comment: Correlations With Neurological Deficit and Histopathological Damage Stroke, November 1, 1999; 30(11): 2448 - 2455. [Abstract] [Full Text] [PDF]

				E. O. Nielsen, T. Varming, C. Mathiesen, L. H. Jensen, A. Møller, A. H. Gouliaev, F. Wätjen, and J. Drejer SPD 502: A Water-Soluble and In Vivo Long-Lasting Ampa Antagonist with Neuroprotective Activity J. Pharmacol. Exp. Ther., June 1, 1999; 289(3): 1492 - 1501. [Abstract] [Full Text]

				A. G. Kanthasamy, R. J. Yun, B. Nguyen, and a. d. d. truong Effect of Riluzole on the Neurological and Neuropathological Changes in an Animal Model of Cardiac Arrest-Induced Movement Disorder J. Pharmacol. Exp. Ther., March 1, 1999; 288(3): 1340 - 1348. [Abstract] [Full Text]

				K. Umemura, T. Gemba, A. Mizuno, M. Nakashima, and K. G Peters Inhibitory Effect of MS-153 on Elevated Brain Glutamate Level Induced by Rat Middle Cerebral Artery Occlusion Stroke, September 1, 1996; 27(9): 1624 - 1628. [Abstract] [Full Text]

				J. Castillo, A. Davalos, J. Naveiro, and M. Noya Neuroexcitatory Amino Acids and Their Relation to Infarct Size and Neurological Deficit in Ischemic Stroke Stroke, June 1, 1996; 27(6): 1060 - 1065. [Abstract] [Full Text]

				T. Shirotani, K. Shima, and H. Chigasaki In Vivo Studies of Extracellular Metabolites in the Striatum After Distal Middle Cerebral Artery Occlusion in Stroke-Prone Spontaneously Hypertensive Rats Stroke, May 1, 1995; 26(5): 878 - 884. [Abstract] [Full Text]

				M. D. Ginsberg REVIEW {blacksquare} : Neuroprotection in Brain Ischemia: An Update (Part I Neuroscientist, March 1, 1995; 1(2): 95 - 103. [Abstract] [PDF]